Alantra advises Accent Equity on the sale of Oral Care to Axcel

Jul 2022

Sell-side advisory

Stockholm – Alantra, the global investment banking firm and asset management specialist, is pleased to announce that it has acted as advisor to Accent Equity, a Swedish private equity firm, on the sale of Oral Care to Axcel.

Founded in 1989, Oral Care is a leading Nordic dental provider operating 14 clinics across Sweden and Norway. The company is a pioneer in the mobile dentistry market, offering on-site treatments to elderly and disabled patients living in care home facilities. Oral Care is renowned as a high-quality care provider with a strong track-record of market consolidation via the acquisition of clinics, as well as patient lists.

Based in Denmark, Axcel is a highly reputable private equity firm dedicated to the Nordic middle market. The firm’s professionals have a strong track record in healthcare and have been following the dental sector for several years. Axcel intends to support Oral Care’s management team in accelerating market consolidation of clinics and expanding its mobile dentistry platform.

Axcel’s expertise and deep understanding of the sector will allow Oral Care to continue its growth and expansion strategy within the Nordic dentistry market.

Daniel Winberg, Partner at Accent Equity, commented: “We are very pleased with the work performed by Alantra on the sale of Oral Care. The Alantra team’s knowledge and previous experience in the dentistry market both locally and in Europe were the decisive factors when selecting the firm as an advisor. In addition, the full commitment of the Nordic team has helped us immensely throughout the sale process. Alantra ran a structured and competitive process, and we are very pleased with the advice and support that we received along the way.”

Jonas Bauréus, Managing Partner at Alantra, said: “We are very pleased to have supported Accent and the management team of Oral Care throughout this exciting process and wish Axcel the best of luck in their journey with the company going forward.”

Christopher Jobst, Partner at Alantra, added: “The sale of Oral Care is another testament to our continued strong momentum within European Healthcare Services, and marks our 10th dental service deal in Europe in recent years. Despite the current market environment, we foresee further M&A momentum and expect ongoing European consolidation in the dental market for the next 12-24 months.”